Llwytho...
Are there benefits to starting HAART during primary HIVinfection? Conclusions from the Seattle Primary Infection Cohort vary by control group
BACKGROUND: It is controversial whether starting highly active antiretroviral therapy (HAART) during primary HIV infection (PHI) is beneficial. METHODS: Subjects in this observational cohort began HAART <30 days (group 1: acute treatment, n=40), 31–180 days (group 2: early treatment, n=82), or &g...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410712/ https://ncbi.nlm.nih.gov/pubmed/22581875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1258/ijsa.2011.011178 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|